| Amy Jo Shannon, SLP | |
|
200 Gaston Ave, Fairmont, WV 26554-2739 | |
| (304) 624-6554 | |
| (304) 624-5223 |
| Full Name | Amy Jo Shannon |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 200 Gaston Ave, Fairmont, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023268281 | NPI | - | NPPES |
| 3810013087 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Jo Shannon, SLP 200 Gaston Ave, Fairmont, WV 26554-2739 Ph: (304) 624-6554 | Amy Jo Shannon, SLP 200 Gaston Ave, Fairmont, WV 26554-2739 Ph: (304) 624-6554 |
News Archive
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
A new study provides important insight into the mechanisms involved in resistance to treatment of breast cancer patients with trastuzumab (Herceptin). The research, published by Cell Press in the October issue of the journal Cancer Cell , identifies markers that may help to identify patients who are unlikely to respond to trastuzumab treatment and provides a potential strategy for treating these patients.
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
New research has revealed that the structure of a bacteriophage, a virus infecting bacteria, resembles that of certain dangerous viruses that infect people.
› Verified 1 days ago
Mrs. Molly Beth Greene, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Gaston Ave, Fairmont, WV 26554 Phone: 304-624-6554 Fax: 304-624-5223 | |
Nicole Danielle Hamrick, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Kaufman Dr, Fairmont, WV 26554 Phone: 304-363-4891 Fax: 304-363-4891 | |
Chelsey Ann Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1712 Locust Ave, Fairmont, WV 26554 Phone: 304-292-0173 Fax: 304-292-0174 | |
Mrs. Madison Paige Crow, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1543 Country Club Rd, Fairmont, WV 26554 Phone: 304-363-2273 | |
Stephanie Rhea Biafore, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Gaston Ave, Fairmont, WV 26554 Phone: 304-624-6554 Fax: 304-624-5223 | |
Susan Jane Rowand, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Gaston Ave, Fairmont, WV 26554 Phone: 304-624-6554 Fax: 304-624-5223 |